October 1, 2026 - 13:13

Emer Cooke, the Executive Director of the European Medicines Agency, addressed a multi-stakeholder workshop focused on women's health, outlining the agency's commitment to closing long-standing gaps in care and treatment. During her remarks, Cooke explained how the EMA is working to ensure that medicines and medical devices are evaluated with women's specific needs in mind, from clinical trial design through to post-authorization monitoring.
She noted that women have historically been underrepresented in certain research areas, which has led to gaps in data on how some treatments affect them. Cooke pointed to ongoing efforts to encourage more inclusive trial populations and to strengthen the collection of sex-disaggregated data so that regulators, clinicians, and patients can make better informed decisions.
The workshop brought together patient groups, healthcare professionals, researchers, and industry representatives to discuss practical steps for improving women's health outcomes. Topics included conditions that disproportionately affect women, such as endometriosis, menopause-related issues, and cardiovascular disease, which is sometimes overlooked in female patients.
Cooke stressed that collaboration across sectors is essential. She said the EMA will continue to engage with stakeholders to make sure women's health remains a priority in regulatory science and that the benefits of new treatments reach all patients who need them. The agency plans to build on these discussions through further workshops and follow-up initiatives in the coming months.
November 16, 2026 - 01:24
The Dangers of Online Healthcare SubscriptionsAs more Australians seek convenient solutions for prescriptions, medical certificates, and weight-loss treatments, online commercial health platforms are gaining popularity. This surge in digital...
November 15, 2026 - 16:50
UCLA Alums Address Critical Health Challenges for VeteransResearchers from the UCLA Fielding School of Public Health are making significant strides in addressing some of the toughest health issues faced by veterans. Their work focuses on a range of...
November 14, 2026 - 20:17
Health Risks and National Security in Hampton RoadsIn a recent column, security expert Douglas P. Harden emphasizes the critical link between public health and national security, particularly in the Hampton Roads area. He argues that military...
November 14, 2026 - 17:08
Investors Overlooked Key Risks in Hims & Hers HealthFor those who invested in Hims & Hers Health a year ago, the experience has been disappointing. A 46.6% loss, dividends included, has left many questioning their decision. Expectations were high,...